Executives to Discuss the Future of IT in Clinical Development, Leveraging Technology and Standards to Improve Trial Data Management and Patient Safety Monitoring

WALTHAM, Mass.--(BUSINESS WIRE)--June 11, 2007--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that the company will participate at the 43rd Annual Meeting of the Drug Information Association (DIA), June 17-21 in Atlanta, Ga. Company executives will discuss several key topics relating to clinical trial data management including electronic health records (EHR), safety signal detection, CDISC and IT interoperability. Session details are as follows:

WHO: Paul A. Bleicher, M.D., Ph.D., Chairman and Founder, Phase Forward (Session Chair)
WHAT: "Leveraging Electronic Health Records in Clinical Research" (Session 299D)
WHEN: Tuesday, June 19, 4:00-5:30 p.m.

WHO: Wayne R. Kubick, Senior Vice President, Phase Forward Lincoln Technologies (Session Chair and Panelist)
WHAT: "Using CDISC Standards and eClinical Technologies to Improve Patient Safety Monitoring During the Conduct of Clinical Trials" (Session 296)
WHEN: Tuesday, June 19, 4:00-5:30 p.m.

WHO: Robbert P. van Manen, Senior Solutions Consultant, Phase Forward Lincoln Technologies (Panelist)
WHAT: "Integrating Information Across the Organization: An Example from Safety" (Session 314)
WHEN: Wednesday, June 20, 8:30-10:00 a.m.

WHO: Robbert P. van Manen, Senior Consultant, Phase Forward Lincoln Technologies (Panelist)
WHAT: "Semantic Web Technologies in Drug Development" (Session 375)
WHEN: Wednesday, June 20, 1:30-3:00 p.m.

WHO: Robert J. Zambarano, Ph.D., Senior Project Manager, Phase Forward Lincoln Technologies (Panelist)
WHAT: "Detecting Safety Signals in Clinical Trials" (Session 397)
WHEN: Wednesday, June 20, 3:30-5:00 p.m.

WHO: Tim Rochford, Chief Technology Officer, Phase Forward (Panelist)
WHAT: "Evolving Technologies for Interoperability" (Session 399F)
WHEN: Wednesday, June 20, 3:30-5:00 p.m.

WHO: Tim Rochford, Chief Technology Officer, Phase Forward (Panelist)
WHAT: "The Future of Information Technology in Clinical Development
and R&D" (Session 411)
WHEN: Thursday, June 21, 8:30-10:00 a.m.

In addition, Phase Forward will showcase its EDC and safety management technologies at booth # 437, including the newly launched Central Designer(TM) product and the Bio-IT World Conference and Expo's Best of Show Finalist - Central Coding(TM) for InForm(TM). Members of the media interested in speaking with Phase Forward at the event should contact Juli Greenwood at CHEN PR at 781-672-3137 or jgreenwood@chenpr.com.

For additional conference information and session details, visit: http://www.diahome.org/en/.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM)), clinical data management (Clintrial(TM)), clinical trials signal detection (CTSD(TM)), strategic pharmacovigilance (WebVDME(TM)) and Signal Management), adverse event reporting (Clintrace(TM)) and applied data standards (WebSDM(TM)). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 250 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, or FDA, GlaxoSmithKline, Harvard Clinical Research Institute, Merck & Co., Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Tibotec, the U.K. Medicines and Healthcare Products Regulatory Agency and Servier. Additional information about Phase Forward is available at www.phaseforward.com.

CONTACT: Phase Forward
Gretchen Dock, 781-902-4413
gretchen.dock@phaseforward.com
or
CHEN PR, Inc.
Juli Greenwood, 781-672-3137
jgreenwood@chenpr.com

SOURCE: Phase Forward